Biller Jonathan

CIK 00017447493 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001744749

Recent Transactions

50 trades

Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$449.00/sh−347→ 15,306 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-10-02$404.21/sh−694→ 15,653 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-10-01$400.00/sh−1,259→ 16,347 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-18$455.06/sh−1,657→ 17,606 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-14$463.46/sh−1,504→ 19,263 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-12+4,437→ 20,767 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-11$459.87/sh−3,433→ 16,330 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-10$467.98/sh−1,632→ 19,763 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-04+4,744→ 21,395 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-10-02$461.66/sh−999→ 16,651 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-10-01$466.84/sh−630→ 17,650 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-12$418.77/sh−1,738→ 18,280 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-09$422.74/sh−1,588→ 20,018 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-07+4,743→ 21,606 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-06+6,294→ 16,863 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2023-10-02$346.76/sh−610→ 10,569 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2023-09-29$350.72/sh−408→ 11,179 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2023-02-01+6,293→ 11,587 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2022-09-19+5,294→ 5,294 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2022-03-01+41,000→ 41,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2022-03-01+11,500→ 11,500 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2022-02-22$29.08/sh−2,688→ 22,953 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2022-02-18−8,523→ 8,522 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2022-02-18+8,523→ 25,641 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2022-02-10+3,667→ 18,467 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2022-02-10$31.43/sh−1,349→ 17,118 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2022-02-10−3,667→ 7,333 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-12-03+5,753→ 16,623 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-12-03$35.88/sh−1,823→ 14,800 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2021-12-03−5,753→ 5,753 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2021-02-10+11,000→ 11,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2021-02-10+44,000→ 44,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2020-12-03−5,753→ 11,506 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-12-03$45.87/sh−1,707→ 10,040 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-12-03+5,753→ 11,747 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-04-14$40.64/sh−2,529→ 5,994 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-04-13+8,523→ 8,523 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2020-04-13−8,523→ 17,045 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2019-12-03+78,824→ 78,824 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2019-12-03+17,259→ 17,259 total
Disposition to Issuer
CELGENE CORP /DE/
Restricted Stock Unit
2019-11-20−6,719→ 0 total
Disposition to Issuer
CELGENE CORP /DE/
Common stock
2019-11-20−478→ 0 total
Disposition to Issuer
CELGENE CORP /DE/
Stock Option (right to buy)
2019-11-20−1,564→ 0 total
Disposition to Issuer
CELGENE CORP /DE/
Stock Option (right to buy)
2019-11-20−3,500→ 0 total
Disposition to Issuer
CELGENE CORP /DE/
Stock Option (right to buy)
2019-11-20−2,344→ 0 total
Disposition to Issuer
CELGENE CORP /DE/
Stock Option (right to buy)
2019-11-20−3,125→ 0 total
Disposition to Issuer
CELGENE CORP /DE/
Stock Option (right to buy)
2019-11-20−3,125→ 0 total
Disposition to Issuer
CELGENE CORP /DE/
Stock Option (right to buy)
2019-11-20−4,688→ 0 total
Disposition to Issuer
CELGENE CORP /DE/
Stock Option (right to buy)
2019-11-20−1,563→ 0 total
Disposition to Issuer
CELGENE CORP /DE/
Stock Option (right to buy)
2019-11-20−3,125→ 0 total

Companies

Recent Filings

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE

BOSTON, MA, 02210

View on SEC.gov